NCT03989986 iPeer2Peer Program for Youth With Sickle Cell Disease Status ACTIVE_NOT_RECRUITING Phase NA
NCT03985501 DREPAMASSE Study - Evaluation of a Newborn Screening for Sickle Cell Disease by Tandem Mass Spectrometry Status COMPLETED Phase N/A
NCT03978156 Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease Status TERMINATED Phase PHASE1
NCT03977532 Study of a Red Blood Cell Deformability Parameter in Patients With Sickle Cell Disease Status COMPLETED Phase NA
NCT03975699 Implications of a Paediatrician-psychologist Tandem for Sickle Cell Disease Care and Impact on Cognitive Functioning Status COMPLETED Phase N/A
NCT03964792 Safety and Efficacy of Gene Therapy of the Sickle Cell Disease by Transplantation of an Autologous CD34+ Enriched Cell Fraction That Contains CD34+ Cells Transduced ex Vivo With the GLOBE1 Lentiviral Vector Expressing the βAS3 Globin Gene in Patients With Sickle Cell Disease (DREPAGLOBE) Status COMPLETED Phase PHASE1/PHASE2
NCT03958643 Best Noninvasive Predictor of Renal Function in Assessing Adult Sickle Nephropathy Status COMPLETED Phase N/A
NCT03944447 Outcomes Mandate National Integration With Cannabis as Medicine Status RECRUITING Phase PHASE2
NCT03943615 Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options Status NO_LONGER_AVAILABLE Phase N/A
NCT03938324 Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions Status COMPLETED Phase NA
NCT03937817 Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants Status RECRUITING Phase N/A
NCT03933397 Comparing Individualized vs. Weight Based Protocols to Treat Vaso-Occlusive Episodes in Sickle Cell Disease Status TERMINATED Phase PHASE3
NCT03919266 Combined Use of a Respiratory Broad Panel Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Hospitalized Sickle-cell Adults With Acute Chest Syndrome. Status COMPLETED Phase NA
NCT03904134 Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation (BMT CTN 1702) Status COMPLETED Phase NA
NCT03903289 The Implementation of the Automated Erythrocytapheresis in Egyptian Sickle Cell Disease Center Status RECRUITING Phase NA
NCT03903133 Endothelial Monocyte-activating Polypeptide-II in Egyptian Sickle Patients Status COMPLETED Phase PHASE4